Compare GDHG & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GDHG | NMTC |
|---|---|---|
| Founded | 2008 | 2009 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.0M | 43.4M |
| IPO Year | 2023 | N/A |
| Metric | GDHG | NMTC |
|---|---|---|
| Price | $1.91 | $0.83 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $2.23 |
| AVG Volume (30 Days) | 7.1K | ★ 237.3K |
| Earning Date | 07-11-2025 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,288,195.00 | $12,097,692.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $32.08 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 250.35 |
| 52 Week Low | $1.82 | $0.40 |
| 52 Week High | $1,968.41 | $1.25 |
| Indicator | GDHG | NMTC |
|---|---|---|
| Relative Strength Index (RSI) | 38.01 | 44.33 |
| Support Level | $1.84 | $0.75 |
| Resistance Level | $2.20 | $0.86 |
| Average True Range (ATR) | 0.13 | 0.06 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 12.96 | 27.17 |
Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, it manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants. it opearts in the Cayman Islands, PRC, BVI, and HK.
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.